The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada
Abstract
Authors
AR Teschemaker C Neslusan S Sabapathy K Yoong P Johansen M Willis